PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 135 filers reported holding PROVENTION BIO INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38 | -60.4% | 1,615 | -86.2% | 0.00% | -50.0% |
Q4 2022 | $96 | -99.8% | 11,669 | -11.5% | 0.01% | +100.0% |
Q3 2022 | $59,000 | +13.5% | 13,190 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -45.3% | 13,190 | -58.1% | 0.00% | -20.0% |
Q1 2022 | $95,000 | +25.0% | 31,490 | -52.4% | 0.01% | +66.7% |
Q4 2021 | $76,000 | -11.6% | 66,090 | +209.0% | 0.00% | -25.0% |
Q3 2021 | $86,000 | +87.0% | 21,390 | +146.1% | 0.00% | +100.0% |
Q2 2021 | $46,000 | +7.0% | 8,690 | +93.5% | 0.00% | 0.0% |
Q1 2021 | $43,000 | +38.7% | 4,490 | -2.4% | 0.00% | +100.0% |
Q4 2020 | $31,000 | +158.3% | 4,600 | -32.4% | 0.00% | – |
Q3 2020 | $12,000 | -42.9% | 6,800 | -21.8% | 0.00% | -100.0% |
Q2 2020 | $21,000 | +90.9% | 8,700 | +89.1% | 0.00% | +100.0% |
Q1 2020 | $11,000 | -56.0% | 4,600 | -42.5% | 0.00% | -50.0% |
Q4 2019 | $25,000 | -39.0% | 8,000 | -3.6% | 0.00% | -33.3% |
Q3 2019 | $41,000 | +412.5% | 8,300 | +492.9% | 0.00% | – |
Q2 2019 | $8,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |